Reuters logo
BRIEF-Catalyst Biosciences and Mosaic Biosciences enter into strategic collaboration
2017年10月24日 / 下午12点45分 / 1 个月前

BRIEF-Catalyst Biosciences and Mosaic Biosciences enter into strategic collaboration

Oct 24 (Reuters) - Catalyst Biosciences Inc:

* Catalyst Biosciences and Mosaic Biosciences enter into strategic collaboration to develop intravitreal anti-complement factor 3 (c3) products for the treatment of dry amd and other retinal diseases

* Catalyst Biosciences - ‍under terms of agreement, co, mosaic will collaborate to improve pharmacokinetic (pk) properties of co’s anti-c3 proteases​

* Catalyst Biosciences Inc - ‍will retain global commercial rights for all collaboration products​

* Catalyst Biosciences Inc - ‍for all collaboration products, mosaic will receive product sublicense fees and/or milestone payments and royalties​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below